Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract - PubMed (original) (raw)

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

P Kristensen et al. J Cell Biol. 1991 Dec.

Abstract

Two mouse urokinase-type plasminogen activator receptor (muPAR) cDNAs were isolated: muPAR1 is homologous to the human urokinase-type plasminogen activator receptor while muPAR2 codes for a 199 residue protein sharing the first 133 residues with muPAR1. Mouse genomic DNA sequencing indicates that the two different mRNAs arise by alternative splicing. In situ hybridization showed differential expression of the two mRNAs in mouse gastric mucosa. muPAR1 mRNA is located in luminal epithelial cells situated close to urokinase-type plasminogen activator-producing connective tissue cells of the lamina propria, pointing to plasmin generation controlled by the cooperation of different cells that may play a role in the release of gastric epithelial cells. muPAR2 mRNA is expressed in the basal epithelial cells, and the deduced protein sequence includes the receptor ligand binding domain, but omits the region involved in glycolipid-mediated membrane anchoring, suggesting that muPAR2 may code for a secreted uPA binding protein.

PubMed Disclaimer

Similar articles

• An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator.
  Pyke C, Eriksen J, Solberg H, Nielsen BS, Kristensen P, Lund LR, Danø K. Pyke C, et al. FEBS Lett. 1993 Jul 12;326(1-3):69-74. doi: 10.1016/0014-5793(93)81763-p. FEBS Lett. 1993. PMID: 8392005
• Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
  Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD. Feng Q, et al. Placenta. 2000 Mar-Apr;21(2-3):184-93. doi: 10.1053/plac.1999.0446. Placenta. 2000. PMID: 10736241
• Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts.
  Rabbani SA, Rajwans N, Achbarou A, Murthy KK, Goltzman D. Rabbani SA, et al. FEBS Lett. 1994 Jan 24;338(1):69-74. doi: 10.1016/0014-5793(94)80118-5. FEBS Lett. 1994. PMID: 8307160
• Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
  Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B. Nordengren J, et al. Mol Hum Reprod. 2004 Sep;10(9):655-63. doi: 10.1093/molehr/gah081. Epub 2004 Jul 8. Mol Hum Reprod. 2004. PMID: 15243126
• Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
  Ploug M, Gårdsvoll H, Jørgensen TJ, Lønborg Hansen L, Danø K. Ploug M, et al. Biochem Soc Trans. 2002 Apr;30(2):177-83. Biochem Soc Trans. 2002. PMID: 12023847 Review.

Cited by

• Serum suPAR in patients with FSGS: trash or treasure?
  Maas RJ, Deegens JK, Wetzels JF. Maas RJ, et al. Pediatr Nephrol. 2013 Jul;28(7):1041-8. doi: 10.1007/s00467-013-2452-5. Epub 2013 Mar 21. Pediatr Nephrol. 2013. PMID: 23515666 Review.
• Generation and characterization of urokinase receptor-deficient mice.
  Dewerchin M, Nuffelen AV, Wallays G, Bouché A, Moons L, Carmeliet P, Mulligan RC, Collen D. Dewerchin M, et al. J Clin Invest. 1996 Feb 1;97(3):870-8. doi: 10.1172/JCI118489. J Clin Invest. 1996. PMID: 8609247 Free PMC article.
• Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.
  Llinas P, Le Du MH, Gårdsvoll H, Danø K, Ploug M, Gilquin B, Stura EA, Ménez A. Llinas P, et al. EMBO J. 2005 May 4;24(9):1655-63. doi: 10.1038/sj.emboj.7600635. Epub 2005 Apr 7. EMBO J. 2005. PMID: 15861141 Free PMC article.
• A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.
  Pedersen N, Schmitt M, Rønne E, Nicoletti MI, Høyer-Hansen G, Conese M, Giavazzi R, Dano K, Kuhn W, Jänicke F, et al. Pedersen N, et al. J Clin Invest. 1993 Nov;92(5):2160-7. doi: 10.1172/JCI116817. J Clin Invest. 1993. PMID: 8227331 Free PMC article.
• Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.
  Cathelin D, Placier S, Ploug M, Verpont MC, Vandermeersch S, Luque Y, Hertig A, Rondeau E, Mesnard L. Cathelin D, et al. J Am Soc Nephrol. 2014 Aug;25(8):1662-8. doi: 10.1681/ASN.2013040425. Epub 2014 May 1. J Am Soc Nephrol. 2014. PMID: 24790179 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6130-3 - PubMed
2. 1. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95 - PubMed
3. 1. J Exp Med. 1978 Mar 1;147(3):745-57 - PubMed
4. 1. Cell. 1976 Oct;9(2):231-40 - PubMed
5. 1. Haemostasis. 1988;18(4-6):328-41 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal